In last week’s Backbench Business debate on the covid-19 pandemic response and trends in excess deaths, I asked whether it is now accepted that it was a mistake to give the respiratory suppressant drug midazolam, as part of National Institute for Health and Care Excellence guideline NG163, as treatment for those suspected of having covid-19. I also asked, should there be legal cases proving unlawful killing linked to overdoses and toxicity from midazolam, who would be held criminally responsible. Would it be the then Secretary of State for Health, NICE, NHS England or the individual doctors and nurses who administered the drug? Those questions were not answered. Can we have a statement from a Health Minister? The evasion and gaslighting on this issue has got to end.
Business of the House
Business question from
Andrew Bridgen
(Independent (affiliation))
in the House of Commons on Thursday, 25 April 2024.
It occurred during Business statement on Business of the House.
Type
Proceeding contribution
Reference
748 c1156 
Session
2023-24
Chamber / Committee
House of Commons chamber
Subjects
Librarians' tools
Timestamp
2024-05-01 14:24:58 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2024-04-25/24042551000072
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2024-04-25/24042551000072
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2024-04-25/24042551000072